Trauma Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Neuroscience Research Center, Baqyiatallah University of Medical Sciences, Tehran, Iran.
Cutan Ocul Toxicol. 2021 Jun;40(2):168-174. doi: 10.1080/15569527.2021.1919138.
Skin lesions are either caused by COVID-19 disease or they can be due to other driving forces related to the COVID-19 pandemic.
Considering the fact that the reported data in different articles for the type and prevalence of skin manifestations related to the COVID-19 pandemic are inconsistent, we have described the mechanism and type of skin lesions related to the COVID-19 pandemic.
In this review article, we have searched the Medline database (PubMed) for the combination of the following key terms "Dermatological Manifestation", "cutaneous Manifestation", "Skin Manifestation", "COVID-19", "SARS-CoV-2".
The prevalence of skin manifestations related to COVID-19 ranged from 0.2% to 20%. The majority of these skin lesions are maculopapular eruptions. The skin presentations related to the COVID-19 pandemic are described below. Traumatic skin conditions such as dermatitis in individuals, especially those with allergies, might initiate secondary to over-washing or rinsing with inappropriate detergents. Also, inappropriate use of personal protective equipment (mask-gloves-shield) can trigger skin lesions on the face and hands or aggravate the lesions of acne, seborrhoeic dermatitis, eczema, etc. Furthermore, cutaneous adverse drug reactions may occur during hospitalization or outpatient treatment of COVID-19 patients. Also, psychocutaneous disorders due to acute stress can trigger or deteriorate several skin manifestations. Moreover, COVID-19 prevalence and course may be changed in patients with autoimmune or chronic inflammatory underlying skin disorders such as psoriasis, lupus erythematosus, pemphigus, scleroderma who are on immunosuppressive or biological medications to control their disorders.
Due to the various dimensions of skin organ involvement and the large population affected, long-term skin conditions following this pandemic can be a lot more problematic than it appears. Serious preventive measures and medical supports are necessary to avoid skin disorders from becoming permanent or even chronic.
皮肤损伤要么由 COVID-19 疾病引起,要么可能由与 COVID-19 大流行相关的其他驱动因素引起。
考虑到不同文章中报道的与 COVID-19 大流行相关的皮肤表现类型和流行率数据不一致,我们描述了与 COVID-19 大流行相关的皮肤损伤的机制和类型。
在这篇综述文章中,我们在 Medline 数据库(PubMed)中搜索了以下关键词的组合:“皮肤表现”、“皮肤表现”、“皮肤表现”、“COVID-19”、“SARS-CoV-2”。
与 COVID-19 相关的皮肤表现的患病率为 0.2%至 20%。这些皮肤病变多数为斑丘疹。与 COVID-19 大流行相关的皮肤表现如下。个体的皮肤创伤性疾病,如过敏人群中的皮炎,可能会因过度洗涤或使用不当的清洁剂冲洗而引发。此外,不当使用个人防护设备(口罩-手套-护罩)可能会在面部和手部引发皮肤损伤,或加重痤疮、脂溢性皮炎、湿疹等的病变。此外,COVID-19 患者住院或门诊治疗期间可能会发生皮肤不良反应。此外,由于急性应激导致的精神皮肤障碍也可能引发或加重几种皮肤表现。此外,COVID-19 的患病率和病程可能会在患有自身免疫性或慢性炎症性基础皮肤疾病(如银屑病、红斑狼疮、天疱疮、硬皮病)的患者中发生变化,这些患者正在服用免疫抑制剂或生物制剂来控制其疾病。
由于皮肤器官受累的各个方面以及受影响的人群庞大,因此此次大流行后的长期皮肤状况可能比表面上更为严重。为避免皮肤疾病永久性甚至慢性化,需要采取认真的预防措施和医疗支持。